Sat, 17 Apr 2021

BEIJING, Feb. 28 (Xinhua) -- The following are the updates on the global fight against the COVID-19 pandemic.

- - - -

SANTIAGO -- Chile reported 4,523 new cases of COVID-19 in the last 24 hours, bringing the country's total to 821,418, of which 23,585 are active, a health official said on Saturday.

Undersecretary of Healthcare Networks Alberto Dougnac explained that the regions with the highest numbers of confirmed cases in the last week are Coquimbo, O'Higgins, Valparaiso, and Los Rios.

- - - -

WASHINGTON -- The U.S. Food and Drug Administration (FDA) on Saturday authorized Johnson & Johnson's COVID-19 vaccine for emergency use in the United States.

It is the third COVID-19 vaccine that has received FDA's emergency use authorization in the country, following the first one developed by American drugmaker Pfizer in partnership with German company BioNTech, and second one developed by American drugmaker Moderna.

- - - -

PARIS -- The number of people who tested positive for COVID-19 in France rose by 23,996 in the past 24 hours, according to figures released by the country's Public Health Agency on Saturday.

The daily tally of new cases, down from Friday's 25,207, has brought the cumulative number of infections to 3,736,016. The country's death toll rose by 186 in a 24-hour span to 86,332.

- - - -

LONDON -- Another 7,434 people in Britain have tested positive for COVID-19, bringing the total number of coronavirus cases in the country to 4,170,519, according to official figures released Saturday.

The country also reported another 290 coronavirus-related deaths. The total number of coronavirus-related deaths in Britain now stands at 122,705. These figures only include the deaths of people who died within 28 days of their first positive test.

- - - -

TUNIS -- Tunisian Health Ministry on Saturday reported 651 new COVID-19 cases, raising the total number of infections in the country to 232,615.

The death toll from the virus rose by 32 to 7,974, the ministry said in a statement.

- - - -

BEIJING -- The Chinese National Medical Products Administration granted conditional market approval to a recombinant novel coronavirus vaccine that requires only one shot.

Developed by a research team led by Chen Wei, an academician at the Chinese Academy of Engineering and a researcher at the Institute of Military Medicine under the Academy of Military Sciences, it is China's first approved COVID-19 vaccine that relies on adenovirus as the vector to deliver the coronavirus spike gene into the body.

More Germany News

Access More

Sign up for Germany News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!